Orient Drugs Private Limited

Orient Drugs Private Limited - pharma in Malappuram, Kerala, India. FY 2026 financials & compliance.
CIN U24231KL1997PTC011301 Incorporated 14 March 1997 ROC Ernakulam HQ Malappuram, Kerala, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2026
₹8.16 Cr
▲ 3% YoY
Net profit · FY 2026
₹2.97 Lakh
Net margin 0.4%
EBITDA · FY 2026
₹4.54 Lakh
EBITDA margin 0.6%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹2 Cr
Issued & subscribed
Satisfied charges
₹1.15 Cr
No open charges
Company age
29 yrs
Est. 1997
Directors on board
9
As per MCA filings

About Orient Drugs Private Limited

Data last updated:

Orient Drugs Private Limited is a private limited company based in Malappuram, Kerala, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 March 1997 and has been in existence for over 29 years.

The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24231KL1997PTC011301. Its GSTIN is 32AAACO2826R1Z8 (Kerala).

The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors including Abdu Avulan (Managing Director) and Favas Avulan.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 2/254 Orient Tower Vadakkemanna Kodur P.O, Malappuram, Kerala, India – 676504.

As per the financials filed for FY 2026, the company reported a revenue of ₹8.16 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹2.97 Lakh (net margin 0.4%) and EBITDA of ₹4.54 Lakh (EBITDA margin 0.6%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 8% over five years.

As per MCA filings, the company has satisfied charges of ₹1.15 Cr on record.

Orient Drugs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-09-0007529). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24231KL1997PTC011301
Registration Number 011301
Incorporation Date 14 March 1997
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-KL-09-0007529

Recognitions & Rankings of Orient Drugs

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-KL-09-0007529

Contact details

Orient Drugs Private Limited's registered office is in Malappuram, Kerala. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    2/254 Orient Tower Vadakkemanna Kodur P.O, Malappuram, Kerala, India – 676504
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Orient Drugs Private Limited, buy the company report.

Comprehensive company report
Orient Drugs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Orient Drugs is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Orient Drugs Private Limited, buy the company report.

Financials of Orient Drugs Private Limited

FY 2026 filings available

Orient Drugs Private Limited reported revenue of ₹8.16 Cr (up 3% YoY) for FY 2026.

Revenue · FY 2026
₹8.16 Cr ▲ 3%
Net profit · FY 2026
₹2.97 Lakh margin 0.4%
EBITDA · FY 2026
₹4.54 Lakh margin 0.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▼ 2%
5 years · compounded
▲ 8%
EBITDA CAGR growth
1 year
▼ 80%
3 years · compounded
▼ 7%

Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 3% growth in the latest year. EBITDA fell 80% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹8.16 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4.54 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.97 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin0.6%
Net Profit Margin0.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Orient Drugs Private Limited, buy the company report.

Board of directors of Orient Drugs Private Limited

Orient Drugs has 9 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Favas AvulanDirector26 Dec 201312 Years 10 MonthsCurrent
Fathima Sheikmoossa AvulanDirector04 Mar 201610 Years 8 MonthsCurrent
Jameela Konndla BadiuzzamanDirector01 Sep 199729 Years 2 MonthsCurrent
Mumtaz PothaparambathDirector01 Sep 199729 Years 2 MonthsCurrent
Zubairali ValiyathodiDirector04 Mar 201610 Years 8 MonthsCurrent
Naseer KalappadenDirector14 Mar 199729 Years 8 MonthsCurrent
Showing 6 of 9 current directors. View all directors

Auditor

Orient Drugs Private Limited is audited by C. SESHADRI NADAN for the financial year 2026.

Auditor firmFinancial yearFirm registration number
C. SESHADRI NADANFY 2026027440

Shareholding

The shareholding of Orient Drugs Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2026FY 2025FY 2024FY 2023FY 2022
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Orient Drugs Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹1.15 Cr
Breakdown by lending institutions
South Indian Bank Limited₹0.90 Cr
The Federal Bank Ltd.₹0.25 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
31 Oct 200710075652South Indian Bank Limited₹90 LakhSatisfied
02 Aug 200490020010The Federal Bank Ltd.₹25 LakhSatisfied

To see the full charge records of Orient Drugs Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Orient Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Orient Drugs has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
32AAACO2826R1Z8KeralaActive01 Jul 2017

To see the full GST registrations and return filing status of Orient Drugs Private Limited, buy the company report.

Recent activity

Orient Drugs Private Limited has 17 board changes on record since 1997: 9 appointments and 8 cessations. The latest: Shibibiyya Mecheri ceased to be Additional Director on 18 Sep 2024.

Filing
Orient Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Ernakulam.
AGM
Orient Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Shibibiyya Mecheri ceased to be Additional Director.
Charges
A charge registered on 31 Oct 2007 via Charge ID 10075652 with South Indian Bank Limited was fully satisfied on 16 Nov 2022.
Ceased
Achamban Thayummu ceased to be Director.
Appointed
Shibibiyya Mecheri was appointed as Director.
Ceased
Naduthody Mannil Mohamed Basheer ceased to be Director.
Ceased
Abdulla Valakkundil ceased to be Director.
Appointed
Fathima Sheikmoossa Avulan was appointed as Director.
Appointed
Zubairali Valiyathodi was appointed as Director.
Ceased
Konnola Badiuzzaman ceased to be Director.
Charges
A charge with South Indian Bank Limited of Rs. 0.90 Cr registered on 31 Oct 2007 with Charge ID 10075652 was modified on 07 Mar 2014.

14 earlier events are in the company report.

Frequently asked questions

Orient Drugs is an active private limited company based in Malappuram, Kerala, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 March 1997 (29+ years old) and is registered under CIN U24231KL1997PTC011301.

Orient Drugs has 9 current directors:

The latest financial statements of Orient Drugs on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Orient Drugs is 32AAACO2826R1Z8, registered in Kerala.

The CIN (Corporate Identification Number) of Orient Drugs is U24231KL1997PTC011301. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Orient Drugs was incorporated on 14 March 1997, making it 29+ years old. It is registered with the Registrar of Companies, Ernakulam.

Shibibiyya Mecheri ceased to be Additional Director on 18 Sep 2024. Achamban Thayummu ceased to be Director on 04 Apr 2022. Shibibiyya Mecheri was appointed as Director on 04 Apr 2022. Orient Drugs has 17 board changes on record in total.

Yes, Orient Drugs is registered as a small enterprise under Udyam registration (number: UDYAM-KL-09-0007529).

The registered office of Orient Drugs is at 2254 Orient Tower Vadakkemanna Kodur P.O, Malappuram, Kerala, India – 676504.

Orient Drugs operates in the pharma industry, in the pharmaceutical retailers and distributors segment.